In vitro, FA inhibits hypoxia-inducible factor-1α (HIF-1α) expression, mitigating HCC-induced hypoxia and angiogenesis via ERK1/2 and JNK-1 suppression, limiting nutrient supply to cancer cells [97]. The gene discussed is MAPK8; the disease is hepatocellular carcinoma.